Background
Methods
The WHO ISs for HBV DNA and HBsAg
Establishment of the RRP
Genotyping of HBV in RRP
Evaluation of in vitro diagnostic kits for HBV DNA and HBsAg
Statistical analysis
Results
Genotype distribution of HBsAg-positive specimens in RRP
Evaluation of HBV DNA kits by WHO IS
DNA-IS | DNA-IS 1 | DNA-IS 2 | DNA- IS 3 | DNA- IS 4 | DNA- IS 5 | DNA- IS 6 | DNA- IS 7 | |
---|---|---|---|---|---|---|---|---|
Theoretical titer (log IU/mL) | 4.0 | 3.5 | 3.0 | 2.5 | 2.0 | 1.5 | 1.0 | |
ART HBV | Titer (log IU/mL) | 3.85 | 3.39 | 2.94 | 2.45 | 2.05 | 1.77 | 1.19 |
CV (%) | 3.75 | 3.14 | 2.00 | 2.00 | 2.50 | 18.0 | 19.0 | |
Alinity HBV | Titer (log IU/mL) | 3.99 | 3.52 | 3.11 | 2.62 | 2.26 | 1.56 | 1.34 |
CV (%) | 0.25 | 0.57 | 3.67 | 4.80 | 13.0 | 4.00 | 34.0 | |
CAP/CTM HBV v2.0 | Titer (log IU/mL) | 4.03 | 3.53 | 3.00 | 2.43 | 2.11 | 1.46 | < 1.30 |
CV (%) | 0.75 | 0.86 | 0.00 | 2.80 | 5.50 | 2.67 | ND | |
Cobas HBV | Titer (log IU/mL) | 3.92 | 3.41 | 2.93 | 2.47 | 1.99 | 1.49 | 1.09 |
CV (%) | 2.00 | 2.57 | 2.33 | 1.20 | 0.50 | 0.67 | 9.00 | |
Aptima HBV | Titer (log IU/mL) | 4.04 | 3.57 | 3.11 | 2.56 | 2.30 | 1.51 | 1.20 |
CV (%) | 1.00 | 2.00 | 3.67 | 2.40 | 15.0 | 0.67 | 20.0 |
Evaluation of HBV DNA kits by RRP
HBV DNA kits | HBV RRP | ||
---|---|---|---|
Negative (n = 64) | Positive (n = 80) | ||
Tested Negative | Tested Positive | Within quantitative range | |
ART HBV | 64 (100%) | 80 (100%) | 77 (96.3%) |
Alinity HBV | 64 (100%) | 79 (98.8%) | 77 (96.3%) |
CAP/CTM HBV v2.0 | 62 (96.9%) | 79 (98.8%) | 72 (90.0%) |
Cobas HBV | 63 (98.4%) | 79 (98.8%) | 76 (95.0%) |
Aptima HBV | 64 (100%) | 80 (100%) | 72 (90.0%) |
Evaluation of HBsAg kits by WHO IS and RRP
HBs-IS | HBs-IS 1 | HBs-IS 2 | HBs-IS 3 | HBs-IS 4 | HBs-IS 5 | HBs-IS 6 | HBs-IS 7 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Theoretical titer (IU/mL) | 3.0 | 1.0 | 0.3 | 0.1 | 0.03 | 0.01 | 0.003 | |||||
Quantitative | Lumipulse (IU/mL) | 3.021 | 1.017 | 0.309 | 0.099 | 0.032 | 0.010 | [0.003] | ||||
Presto (IU/mL) | 3.206 | 1.111 | 0.330 | 0.111 | 0.034 | 0.011 | [0.003] | |||||
HISCL (IU/mL) | 3.41 | 1.12 | 0.34 | 0.10 | 0.03 | [0.01] | [0.00] | |||||
CL AIA (IU/mL) | 2.54 | 0.90 | 0.27 | 0.10 | 0.03 | [0.01] | [0.01] | |||||
Accuraseed (IU/mL) | 3.66 | 1.16 | 0.35 | 0.12 | 0.05 | [0.00] | [0.00] | |||||
Architect (IU/mL) | 4.20 | 1.46 | 0.43 | 0.14 | [0.03] | [0.00] | [0.00] | |||||
Alinity (IU/mL) | 4.15 | 1.40 | 0.49 | 0.16 | 0.05 | [0.02] | [0.00] | |||||
Elecsys quant II (IU/mL) | 2.93 | 0.944 | 0.279 | 0.0859 | [0.05 <] | [0.05 <] | [0.05 <] | |||||
Qualitative | ST AIA (IU/mL) | 2.66 | 0.86 | 0.25 | 0.08 | [0.03] | [0.01] | [0.00] | ||||
STACIA (COI) | 60.9 | 20.7 | 6.1 | 2.0 | [0.6] | [0.2] | [0.1] | |||||
Centaur II (Index) | 204.05 | 63.42 | 17.03 | 5.66 | 1.61 | [0.55] | [0.26] | |||||
Elecsys II (COI) | 56.6 | 19.7 | 6.08 | 2.27 | 1.05 | [0.648] | [0.53] | |||||
LFA | Determine (+/-) | + | + | - | - | - | - | - | ||||
Determine2 (+/-) | + | + | + | + | - | - | - |
HBsAg kits | HBV RRP | ||
---|---|---|---|
Negative (n = 64) Tested Negative | Positive (n = 80) Tested positive | ||
Quantitative | Lumipulse | 64 (100%) | 80 (100%) |
Presto | 64 (100%) | 80 (100%) | |
HISCL | 64 (100%) | 80 (100%) | |
CL AIA | 64 (100%) | 80 (100%) | |
Accuraseed | 64 (100%) | 80 (100%) | |
Architect | 64 (100%) | 80 (100%) | |
Alinity | 64 (100%) | 80 (100%) | |
Elecsys quant II | 64 (100%) | 80 (100%) | |
Qualitative | ST AIA | 64 (100%) | 79 (98.8%) |
STACIA | 64 (100%) | 79 (98.8%) | |
Centaur II | 64 (100%) | 80 (100%) | |
Elecsys II | 64 (100%) | 80 (100%) | |
LFA | Determine | 64 (100%) | 75 (93.8%) |
Determine2 | 64 (100%) | 80 (100%) |